Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-013539
Filing Date
2006-02-27
Accepted
2006-02-27 17:30:35
Documents
1
Period of Report
2006-02-23

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b59420pb.html 4  
1 MAIN DOCUMENT DESCRIPTION b59420pb.xml 4 21976
  Complete submission text file 0001209191-06-013539.txt   23873
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC. 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 617-252-0700
Barrett Peter (Reporting) CIK: 0001291895 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 06647765